Compare RVSB & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVSB | SRTS |
|---|---|---|
| Founded | 1923 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.9M | 44.3M |
| IPO Year | 1997 | 2016 |
| Metric | RVSB | SRTS |
|---|---|---|
| Price | $5.41 | $3.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $7.00 | $7.00 |
| AVG Volume (30 Days) | ★ 185.8K | 38.8K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.55% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | $53.63 | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.74 | $2.66 |
| 52 Week High | $6.22 | $5.92 |
| Indicator | RVSB | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 53.49 |
| Support Level | $5.33 | $2.82 |
| Resistance Level | $5.51 | $3.28 |
| Average True Range (ATR) | 0.26 | 0.13 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 23.86 | 91.11 |
Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment services. It has single operating segment.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.